Haploidentical T-cell alpha beta receptor and CD19–depleted stem cell transplant for Wiskott-Aldrich syndrome - 07/11/14
Doi : 10.1016/j.jaci.2014.04.041
Gaurav Kharya, MD a, Zohreh Nademi, PhD a, b, T. Ronan Leahy, MB, MRCPI a, Janice Dunn c, Dawn Barge, PhD d, Ansgar Schulz, MD e, Andrew Cant, MD a, b, Andrew Gennery, MD a, b, Mary Slatter, MD a, b 
a Department of Paediatric Immunology, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom
b Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom
c Haematology Transplant Laboratory, Cellular Therapies Facility, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom
d Regional Immunology Laboratory, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom
e Department of Pediatrics and Adolescent Medicine, University Medical Center, Ulm, Germany
| Disclosure of potential conflict of interest: M. Slatter has received travel support from MEDAC Pharma. The rest of the authors declare that they have no relevant conflicts of interest. |
Crown Copyright © 2014
Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 134 - N° 5
P. 1199-1201 - novembre 2014 Retour au numéro
Article précédent
- High serum corticotropin-releasing hormone (CRH) and bone marrow mast cell CRH receptor expression in a mastocytosis patient
- Theoharis C. Theoharides, Anastasia I. Petra, Julia M. Stewart, Irene Tsilioni, Smaro Panagiotidou, Cem Akin
- HLA-DRB1*15:01 allele protects from asthma susceptibility
- María Pino-Yanes, Almudena Corrales, Marialbert Acosta-Herrera, Eva Pérez-Rodríguez, José Cumplido, Paloma Campo, Amalia Barreto-Luis, Florentino Sánchez-García, Tobías Felipe, Inmaculada Sánchez-Machín, Inés Quintela, José Carlos García-Robaina, Jesús Villar, Miguel Blanca, Angel Carracedo, Teresa Carrillo, Carlos Flores
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?